CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GALDY

Phase 3

Development Phase

2

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Oct '26
GALDYPhase 3

Nemolizumab Phase 3 Est. Readout

Nemolizumab
Oct 2026~
CT.gov
00%
Sep '26
GALDYPhase 2

nemolizumab Phase 2 Est. Readout

Nemolizumab
Sep 2026~STALE+IMMINENT
CT.gov
00%
Development History
Aug '26
GALDYPhase 3

Nemolizumab Phase 3 Est. Readout

Nemolizumab
Aug 2026~
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Prurigo Nodularis

Clinical Trial

NCT04204616

Last updated: 1/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.